PL434216A1 - Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania - Google Patents

Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania

Info

Publication number
PL434216A1
PL434216A1 PL434216A PL43421620A PL434216A1 PL 434216 A1 PL434216 A1 PL 434216A1 PL 434216 A PL434216 A PL 434216A PL 43421620 A PL43421620 A PL 43421620A PL 434216 A1 PL434216 A1 PL 434216A1
Authority
PL
Poland
Prior art keywords
azabicyclo
triazol
phenylethyl
octane
derivatives
Prior art date
Application number
PL434216A
Other languages
English (en)
Other versions
PL241225B1 (pl
Inventor
Elżbieta Wojaczyńska
Franz Steppeler
Original Assignee
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska filed Critical Politechnika Wrocławska
Priority to PL434216A priority Critical patent/PL241225B1/pl
Publication of PL434216A1 publication Critical patent/PL434216A1/pl
Publication of PL241225B1 publication Critical patent/PL241225B1/pl

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku są pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu lub (1S,4R,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu, oraz sposób ich wytwarzania. Pochodne te przeznaczone są do stosowania w medycynie jako środki zwalczające komórki rakowe.
PL434216A 2020-06-05 2020-06-05 Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania PL241225B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL434216A PL241225B1 (pl) 2020-06-05 2020-06-05 Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434216A PL241225B1 (pl) 2020-06-05 2020-06-05 Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania

Publications (2)

Publication Number Publication Date
PL434216A1 true PL434216A1 (pl) 2021-12-06
PL241225B1 PL241225B1 (pl) 2022-08-22

Family

ID=80002107

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434216A PL241225B1 (pl) 2020-06-05 2020-06-05 Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania

Country Status (1)

Country Link
PL (1) PL241225B1 (pl)

Also Published As

Publication number Publication date
PL241225B1 (pl) 2022-08-22

Similar Documents

Publication Publication Date Title
MX2025011774A (es) Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2
CR20220537A (es) [1,3]DIAZINO[5,4-d]PIRIMIDINAS COMO INHIBIDORES DE HER2
MX2025011533A (es) Aminas biciclicas como inhibidores de la cinasa dependiente de ciclina 2 (cdk2)
PH12020550986A1 (en) Heterocyclylamino-substituted triazoles as modulators of rho-associated protein kinase
GEAP202415945A (en) Bicyclic heterocycles as fgfr inhibitors
PE20220750A1 (es) Imidazopirimidinas como inhibidores de eed y uso de estas
HRP20050967B1 (hr) Derivati pirazolo-kinazolina, postupak njihovog dobivanja i njihova uporaba kao inhibitora kinaze
ZA202205900B (en) 5-(2-(2,5-difluorophenyl)pyrrolidin-1 -yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancer
FR16C0021I2 (fr) Azetidines en tant qu'inhibiteurs de mek et leur utilisation pour le traitement des maladies proliferatives
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
MA38391A1 (fr) Dérivés de pyridinyl et triazolone pyridinyl de fusion
MX2024013020A (es) Compuestos de heteroarilo para el tratamiento del dolor
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
MX2023002792A (es) Preparacion farmaceutica.
PH12022551960A1 (en) Antibodies binding to b7h4
CR20240514A (es) Compuestos de heteroarilo para el tratamiento del dolor
ZA202203520B (en) [1,4]oxazepino[2,3-c]quinolinone derivatives as bcl6 inhibitors
IL158116A0 (en) Inhibitors of cyclin dependent kinases as anti-cancer agent
CR20200463A (es) Anticuerpos
AU2020288559A8 (en) Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists
WO2019199667A3 (en) Pladienolide compounds and their use
PH12019502086A1 (en) Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
BR112022022932A2 (pt) Inibidor de vcp/p97 para o tratamento do câncer
ATE546452T1 (de) Pyrazolopyrrolderivate als proteinkinaseinhibitoren
WO2019016597A3 (en) SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES